Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?

Table 3 Intra-group comparison of vision and cube average thickness values before and 1 month after bevacizumab injection

	Baseline VA (LogMAR) median (IQR)	1 Month VA (LogMAR) median (IQR)	P-value	Baseline CAT (μm) median (IQR)	1 Month CAT (μm) median (IQR)	P-value
NPDR group	0.9 (0.5–1.0)	0.4 (0.2–0.7)	0.011^e	337 (297–361)	301 (269–324)	0.005^a
PDR group	0.8 (0.5–1.0)	0.3 (0.2–0.5)	0.001^e	364 (341–378)	305 (288–337)	0.001^a

VA Visual acuity, LogMAR The logarithm of the minimum resolution angle, IQR Interquartile range, CAT Cube average thickness, NPDR Non-proliferative diabetic retinopathy, PDR Proliferative diabetic retinopathy Note: ^aWilcoxon Rank Test

ISSN: 1471-2415